These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11698691)

  • 41. Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin.
    Roy D; Angelini NL; Fujieda H; Brown GM; Belsham DD
    Endocrinology; 2001 Nov; 142(11):4711-20. PubMed ID: 11606436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Melatonin differentially modulates the expression and function of the hMT1 and hMT2 melatonin receptors upon prolonged withdrawal.
    Masana MI; Witt-Enderby PA; Dubocovich ML
    Biochem Pharmacol; 2003 Mar; 65(5):731-9. PubMed ID: 12628486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral melatonin mediates neural stimulation of duodenal mucosal bicarbonate secretion.
    Sjöblom M; Jedstedt G; Flemström G
    J Clin Invest; 2001 Aug; 108(4):625-33. PubMed ID: 11518737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin: Physiological effects in humans.
    Claustrat B; Leston J
    Neurochirurgie; 2015; 61(2-3):77-84. PubMed ID: 25908646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism.
    Zalatan F; Krause JA; Blask DE
    Endocrinology; 2001 Sep; 142(9):3783-90. PubMed ID: 11517154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melatonin and cardiovascular function.
    Krause DN; Geary GG; Doolen S; Duckles SP
    Adv Exp Med Biol; 1999; 460():299-310. PubMed ID: 10810525
    [No Abstract]   [Full Text] [Related]  

  • 47. Photoperiodic signalling through the melatonin receptor turns full circle.
    Morgan PJ; Hazlerigg DG
    J Neuroendocrinol; 2008 Jun; 20(6):820-6. PubMed ID: 18601705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antioxidant properties of melatonin--an emerging mystery.
    Beyer CE; Steketee JD; Saphier D
    Biochem Pharmacol; 1998 Nov; 56(10):1265-72. PubMed ID: 9825724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Melatonin in relation to physiology in adult humans.
    Cagnacci A
    J Pineal Res; 1996 Nov; 21(4):200-13. PubMed ID: 8989718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.
    Pandi-Perumal SR; Trakht I; Srinivasan V; Spence DW; Maestroni GJ; Zisapel N; Cardinali DP
    Prog Neurobiol; 2008 Jul; 85(3):335-53. PubMed ID: 18571301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues.
    Wiechmann AF; Summers JA
    Prog Retin Eye Res; 2008 Mar; 27(2):137-60. PubMed ID: 18316227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nycthemeral variations of cholecystokinin action on intestinal motility in rats: effects of melatonin and S 20928, a melatonin receptor antagonist.
    Merle A; Faucheron JL; Delagrange P; Renard P; Roche M; Pellissier S
    Neuropeptides; 2000 Dec; 34(6):385-91. PubMed ID: 11162294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin.
    von Gall C; Garabette ML; Kell CA; Frenzel S; Dehghani F; Schumm-Draeger PM; Weaver DR; Korf HW; Hastings MH; Stehle JH
    Nat Neurosci; 2002 Mar; 5(3):234-8. PubMed ID: 11836530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Photoperiodic regulation of MT1 and MT2 melatonin receptor expression in spleen and thymus of a tropical rodent Funambulus pennanti during reproductively active and inactive phases.
    Ahmad R; Haldar C
    Chronobiol Int; 2010 May; 27(3):446-62. PubMed ID: 20524795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human circadian rhythms: physiological and therapeutic relevance of light and melatonin.
    Skene DJ; Arendt J
    Ann Clin Biochem; 2006 Sep; 43(Pt 5):344-53. PubMed ID: 17022876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melatonin normalizes the re-entrainment of senescence accelerated mice (SAM) to a new light-dark cycle.
    Shibata S; Asai M; Oshima I; Ikeda M; Yoshioka T
    Adv Exp Med Biol; 1999; 460():261-70. PubMed ID: 10810521
    [No Abstract]   [Full Text] [Related]  

  • 57. Identification of the melatonin-binding site MT3 as the quinone reductase 2.
    Nosjean O; Ferro M; Coge F; Beauverger P; Henlin JM; Lefoulon F; Fauchere JL; Delagrange P; Canet E; Boutin JA
    J Biol Chem; 2000 Oct; 275(40):31311-7. PubMed ID: 10913150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic perspectives for melatonin agonists and antagonists.
    Delagrange P; Atkinson J; Boutin JA; Casteilla L; Lesieur D; Misslin R; Pellissier S; Pénicaud L; Renard P
    J Neuroendocrinol; 2003 Apr; 15(4):442-8. PubMed ID: 12622848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular pharmacology and function of melatonin receptor subtypes.
    Dubocovich ML; Masana MI; Benloucif S
    Adv Exp Med Biol; 1999; 460():181-90. PubMed ID: 10810513
    [No Abstract]   [Full Text] [Related]  

  • 60. [Research progress in the oncostatic mechanism of melatonin].
    Gao L; Xu RK
    Sheng Li Ke Xue Jin Zhan; 2001 Apr; 32(2):160-2. PubMed ID: 12545891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.